12-82358343-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014167.5(CCDC59):c.34C>T(p.Pro12Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000112 in 1,613,706 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014167.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCDC59 | NM_014167.5 | c.34C>T | p.Pro12Ser | missense_variant | 1/4 | ENST00000256151.8 | |
CCDC59 | NR_033192.1 | n.127+336C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCDC59 | ENST00000256151.8 | c.34C>T | p.Pro12Ser | missense_variant | 1/4 | 1 | NM_014167.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000132 AC: 33AN: 250000Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135526
GnomAD4 exome AF: 0.000112 AC: 163AN: 1461420Hom.: 0 Cov.: 36 AF XY: 0.000117 AC XY: 85AN XY: 727054
GnomAD4 genome AF: 0.000118 AC: 18AN: 152286Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2024 | The c.34C>T (p.P12S) alteration is located in exon 1 (coding exon 1) of the CCDC59 gene. This alteration results from a C to T substitution at nucleotide position 34, causing the proline (P) at amino acid position 12 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at